NEW YORK, Oct. 20, 2016 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Tyson Foods, Inc. (NYSE:TSN) (hereinafter “Tyson”) in the United States District Court for the Southern District of New York, on behalf of all persons who purchased or otherwise acquired securities of Tyson between November 23, 2015 and October 6, 2016 (the “Class Period”).
The Complaint alleges that Defendants concealed from the investing public that: (i) since 2008, Tyson Foods has colluded with the country’s leading poultry producers to manipulate the supply of broiler-chickens in order to keep the price of broiler-chickens artificially high; (ii) from 2013-2016, Tyson Foods exported hatching eggs to Mexico and other foreign countries to artificially reduce the supply of broiler-chickens in the U.S. and to increase the price of broiler-chickens in the U.S.; (iii) in turn, Tyson Foods lacked effective internal control over financial reporting; and (iv) as a result, Tyson Foods’ public statements were materially false and misleading at all relevant times. As a result of Defendants’ alleged false and misleading statements, the Company’s stock traded at artificially inflated prices during the Class Period.
According to the Complaint, on October 7, 2016, Pivotal Research issued a report (the “Pivotal Research Report”) downgrading Tyson Foods to “sell” from “buy,” and slashing its price target from $100 to $40. The Pivotal Research Report noted that a recent federal antitrust lawsuit is a “powerfully convincing class-action” and that if the allegations therein are true, “[i]t explains why Tyson can offer EPS guidance with remarkable precision; boasting of margins at record levels well into the future. The Tyson of old did not provide guidance. We believe the consistent setting and meeting of earnings targets has been a major factor in the positive re-rating of the shares.”
On this news, shares of Tyson Foods dropped over 8%, closing at $67.75 per share on October 7, 2016, on heavy trading volume.
Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm prior to the December 16, 2016 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Italy Fines Apple €98.6 Million Over App Store Dominance 



